Item 9 Labs Corp. Announces the Filing of Form 10 Registration Statement with the Securities and Exchange Commission
PHOENIX, July 02, 2019 (GLOBE NEWSWIRE) — Item 9 Labs Corp. (OTC: INLB) (“Item 9 Labs” or the “Company”), a leader in comfortable cannabis health solutions for the modern consumer, announced the filing of a Form 10 with the U.S. Securities and Exchange Commission (“SEC”). The filing provides investor detailed information on Item 9 Labs business, operations, overview of business strategy, risk factors and audited financial results.
Following the effective date of the Form 10, the Company will be subject to the reporting requirements of the Exchange Act of 1934, as amended, including requirements to begin filing reports on Form 10-K, Form 10-Q, and Form 8-K and subjects itself to additional reporting obligations related to proxies, shareholder actions and stock ownership rules.
“Filing the Form 10 is a significant milestone for the Company, adding value, liquidity and transparency for our shareholders. Becoming a fully reporting public company is a milestone that sets the stage for our commitment to our growth strategy and we are grateful for our shareholders continued support,” stated Bobby Mikkelsen, CFO at Item 9 Labs.
A copy of the filing is available on the SEC’s website at www.sec.gov under the name Item 9 Labs Corp.